BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17638534)

  • 1. High throughput screening assay for UDP-glucuronosyltransferase 1A1 glucuronidation profiling.
    Trubetskoy OV; Finel M; Kurkela M; Fitzgerald M; Peters NR; Hoffman FM; Trubetskoy VS
    Assay Drug Dev Technol; 2007 Jun; 5(3):343-54. PubMed ID: 17638534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-based high-throughput screening assay for drug interactions with UGT1A6.
    Soikkeli A; Kurkela M; Hirvonen J; Yliperttula M; Finel M
    Assay Drug Dev Technol; 2011 Oct; 9(5):496-502. PubMed ID: 21438674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening technologies for drug glucuronidation profiling.
    Trubetskoy O; Finel M; Trubetskoy V
    J Pharm Pharmacol; 2008 Aug; 60(8):1061-7. PubMed ID: 18644198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors.
    Zhou QH; Qin WW; Finel M; He QQ; Tu DZ; Wang CR; Ge GB
    Int J Biol Macromol; 2021 Jun; 180():252-261. PubMed ID: 33741369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
    Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
    Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate.
    Marks BD; Smith RW; Braun HA; Goossens TA; Christenson M; Ozers MS; Lebakken CS; Trubetskoy OV
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):73-81. PubMed ID: 15090158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
    Al Saabi A; Allorge D; Sauvage FL; Tournel G; Gaulier JM; Marquet P; Picard N
    Drug Metab Dispos; 2013 Mar; 41(3):568-74. PubMed ID: 23230132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7.
    Fang ZZ; Wang H; Cao YF; Sun DX; Wang LX; Hong M; Huang T; Chen JX; Zeng J
    Chirality; 2015 Mar; 27(3):189-93. PubMed ID: 25502512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automation and miniaturization of the bioluminescent UGT-Glo assay for screening of UDP-glucuronosyltransferase inhibition by various compounds.
    Larson B; Kelts JL; Banks P; Cali JJ
    J Lab Autom; 2011 Feb; 16(1):38-46. PubMed ID: 21609684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.
    Baranczewski P; Kallin A; Andersson A; Hagigi S; Aberg M; Postlind H; Mankowitz L
    Assay Drug Dev Technol; 2004 Aug; 2(4):345-52. PubMed ID: 15357915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors.
    Zhou QH; Lv X; Tian ZH; Finel M; Feng L; Huo PC; Zhu YD; Lu Y; Hou J; Ge GB
    Anal Chim Acta; 2021 Apr; 1153():338305. PubMed ID: 33714444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assay of six UDP-glucuronosyltransferase isoforms in human liver microsomes, using cocktails of probe substrates and liquid chromatography-tandem mass spectrometry.
    Seo KA; Kim HJ; Jeong ES; Abdalla N; Choi CS; Kim DH; Shin JG
    Drug Metab Dispos; 2014 Nov; 42(11):1803-10. PubMed ID: 25122565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications.
    Lv X; Ge GB; Feng L; Troberg J; Hu LH; Hou J; Cheng HL; Wang P; Liu ZM; Finel M; Cui JN; Yang L
    Biosens Bioelectron; 2015 Oct; 72():261-7. PubMed ID: 25988789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1.
    Terai T; Tomiyasu R; Ota T; Ueno T; Komatsu T; Hanaoka K; Urano Y; Nagano T
    Chem Commun (Camb); 2013 Apr; 49(30):3101-3. PubMed ID: 23338213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Practical and High-Affinity Fluorescent Probe for Uridine Diphosphate Glucuronosyltransferase 1A1: A Good Surrogate for Bilirubin.
    Lv X; Feng L; Ai CZ; Hou J; Wang P; Zou LW; Cheng J; Ge GB; Cui JN; Yang L
    J Med Chem; 2017 Dec; 60(23):9664-9675. PubMed ID: 29125289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
    Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
    Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs).
    Zhou J; Miners JO
    Methods Mol Biol; 2014; 1113():203-28. PubMed ID: 24523115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chirality Influence of Zaltoprofen Towards UDP-Glucuronosyltransferases (UGTs) Inhibition Potential.
    Jia L; Hu C; Wang H; Liu Y; Liu X; Zhang YY; Li W; Wang LX; Cao YF; Fang ZZ
    Chirality; 2015 Jun; 27(6):359-63. PubMed ID: 25903196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.